Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-16-013594
Filing Date
2016-04-01
Accepted
2016-04-01 21:05:54
Documents
1
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1600924_carlson.html 4  
1 OWNERSHIP DOCUMENT t1600924_carlson.xml 4 12831
  Complete submission text file 0001571049-16-013594.txt   14470
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2496 OLD BEACH ROAD WAYZATA MN 55391
Business Address
Carlson Gerald K (Reporting) CIK: 0001601343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 161548669